![Christina Cognata-Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Christina Cognata-Smith is the founder and currently holds the position of Chief Scientific Officer at DAS Therapeutics, Inc. which is founded in 2019.
Aktive Positionen von Christina Cognata-Smith
Unternehmen | Position | Beginn |
---|---|---|
DAS Therapeutics, Inc.
![]() DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DAS Therapeutics, Inc. is a clinical stage pharmaceutical company. It acquires and develops assets for conditions overlooked or under-served by current treatment approaches to improve patient outcomes. The company was founded by Raimonds Dzelme, Christina Cognata-Smith and Michael Nemmers in 2016 and is headquartered in Boston, MA. | Gründer | 01.01.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
DAS Therapeutics, Inc.
![]() DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DAS Therapeutics, Inc. is a clinical stage pharmaceutical company. It acquires and develops assets for conditions overlooked or under-served by current treatment approaches to improve patient outcomes. The company was founded by Raimonds Dzelme, Christina Cognata-Smith and Michael Nemmers in 2016 and is headquartered in Boston, MA. | Health Technology |